However, combined treatment with sh-EGR1 and oe-TLR4 could aggravate I/R injury by augmenting the LDH and CK activity in arterial blood and increasing myocardial infarct size and cardiomyocyte apoptosis (Figures 6(i)–(k)). This evidence concerns the gene TLR4 and myocardial infarction.